Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1333462.RANUj6uBxOb5j5ov0Q_b-PjdoTOxL_6aLhIoT1Sg0CqJQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1333462.RANUj6uBxOb5j5ov0Q_b-PjdoTOxL_6aLhIoT1Sg0CqJQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1333462.RANUj6uBxOb5j5ov0Q_b-PjdoTOxL_6aLhIoT1Sg0CqJQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1333462.RANUj6uBxOb5j5ov0Q_b-PjdoTOxL_6aLhIoT1Sg0CqJQ130_provenance.
- befree-2016 importedOn "2016-02-19" NP1333462.RANUj6uBxOb5j5ov0Q_b-PjdoTOxL_6aLhIoT1Sg0CqJQ130_provenance.
- NP1333462.RANUj6uBxOb5j5ov0Q_b-PjdoTOxL_6aLhIoT1Sg0CqJQ130_assertion wasGeneratedBy ECO_0000203 NP1333462.RANUj6uBxOb5j5ov0Q_b-PjdoTOxL_6aLhIoT1Sg0CqJQ130_provenance.
- NP1333462.RANUj6uBxOb5j5ov0Q_b-PjdoTOxL_6aLhIoT1Sg0CqJQ130_assertion wasDerivedFrom befree-2016 NP1333462.RANUj6uBxOb5j5ov0Q_b-PjdoTOxL_6aLhIoT1Sg0CqJQ130_provenance.
- NP1333462.RANUj6uBxOb5j5ov0Q_b-PjdoTOxL_6aLhIoT1Sg0CqJQ130_assertion SIO_000772 8128981 NP1333462.RANUj6uBxOb5j5ov0Q_b-PjdoTOxL_6aLhIoT1Sg0CqJQ130_provenance.
- NP1333462.RANUj6uBxOb5j5ov0Q_b-PjdoTOxL_6aLhIoT1Sg0CqJQ130_assertion evidence source_evidence_literature NP1333462.RANUj6uBxOb5j5ov0Q_b-PjdoTOxL_6aLhIoT1Sg0CqJQ130_provenance.
- NP1333462.RANUj6uBxOb5j5ov0Q_b-PjdoTOxL_6aLhIoT1Sg0CqJQ130_assertion description "[Two major types can be distinguished based on electrophysiologic phenotypes: CMT type 1 (CMT1) displays uniformly decreased nerve conduction velocity associated with a demyelinating hypertrophic neuropathy, and CMT type 2 (CMT2) displays normal or near-normal nerve conduction velocity associated with a neuronal defect.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1333462.RANUj6uBxOb5j5ov0Q_b-PjdoTOxL_6aLhIoT1Sg0CqJQ130_provenance.